“This grant will allow us to continue research into a new drug candidate that our group developed and that has shown evidence of stopping and correcting what goes wrong in the lungs when this type of disease process is triggered,” Holtzman added.
https://copdnewstoday.com/2020/08/18/washington-university-given-nearly-4-million-grant-advance-copd-therapy-to-clincial-testing/